Verrica Pharmaceuticals Inc. (VRCA) Earnings
|
Expand Research on VRCA
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +108.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/25  |
Q325 | $0.13 | -$0.08 | +$0.21 | $14.3M | $5.34M | N/A |  | | Details | |
| 11/10/25 |
Q325 | N/A | -$0.08 | N/A | N/A | $5.34M | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | $0.02 | -$0.09 | +$0.11 | $12.7M | $4.11M | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.08 | -$0.11 | +$0.03 | $3.44M | $2.48M | N/A | | | Details | |
| 5/7/25 |
Q125 | N/A | -$0.11 | N/A | N/A | $2.48M | N/A | N/A | N/A | ||
| 3/11/25 | Q424 | -$0.24 | -$0.30 | +$0.06 | $340K | $532.75K | N/A | | | Details | |
| 3/3/25 |
Q424 | N/A | -$0.30 | N/A | N/A | $532.75K | N/A | N/A | N/A | ||
| 2/28/25 |
Q424 | N/A | -$0.30 | N/A | N/A | $532.75K | N/A | N/A | N/A |
